These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 24696598)
1. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects. Lee SC; Tan HT; Chung MC World J Gastroenterol; 2014 Mar; 20(12):3112-24. PubMed ID: 24696598 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence. Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119 [TBL] [Abstract][Full Text] [Related]
3. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153 [TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery. Niu D; Feng H; Chen WN J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222 [TBL] [Abstract][Full Text] [Related]
5. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis. Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173 [TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439 [TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283 [TBL] [Abstract][Full Text] [Related]
9. New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma. Ji J; Wang XW Cancer Biol Ther; 2009 Sep; 8(18):1686-93. PubMed ID: 19901517 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Mínguez B; Lachenmayer A Dis Markers; 2011; 31(3):181-90. PubMed ID: 22045404 [TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Tang Y; Zhang Y; Hu X Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723 [TBL] [Abstract][Full Text] [Related]
12. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy. Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Zhu J; Tang B; Li J; Shi Y; Chen M; Lv X; Meng M; Weng Q; Zhang N; Fan K; Xu M; Ji J Aging (Albany NY); 2020 May; 12(9):7848-7873. PubMed ID: 32379058 [TBL] [Abstract][Full Text] [Related]
14. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma. Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388 [TBL] [Abstract][Full Text] [Related]
15. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma. Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317 [TBL] [Abstract][Full Text] [Related]
16. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Yi X; Luk JM; Lee NP; Peng J; Leng X; Guan XY; Lau GK; Beretta L; Fan ST Mol Cell Proteomics; 2008 Feb; 7(2):315-25. PubMed ID: 17934217 [TBL] [Abstract][Full Text] [Related]
17. Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival. Nagai S; Mangus RS; Kubal CA; Ekser B; Fridell JA; Klingler KR; Maluccio MA; Tector AJ Clin Transplant; 2015 Dec; 29(12):1156-63. PubMed ID: 26458066 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma. Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135 [No Abstract] [Full Text] [Related]
19. Multiple-Scales Integrative Analysis of MicroRNAs Unveils Biomarkers and Key Regulatory Connections for Hepatocellular Carcinoma. Qian K; Li Q; Deng W; Xiang X Crit Rev Eukaryot Gene Expr; 2019; 29(3):189-241. PubMed ID: 31679233 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma. Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]